Chuanhuning treatment of respiratory tract infections adverse events of clinical observation and analysis of.docVIP

 PAGE \* MERGEFORMAT 11 Chuanhuning treatment of respiratory tract infections adverse events of clinical observation and analysis of Author: Gao Tian, Yan, Luo was expensive, Yang Juan, Luo Heroes Abstract in clinical medicine to understand the process of drug safety and efficacy of drug control is equally important to enhance awareness of drug safety and monitoring will help reduce the risk of drug use, improve the level of rational drug use. Adverse drug event in clinical medicine, the eligible amount of drugs in that occur under normal usage with the drug unrelated to the purpose of harmful events, such a causal relationship between the event and medicine can not be determined. This paper Chuanhuning injection in the clinical treatment of viral pneumonia, viral upper respiratory tract infections adverse events observed in an analysis, conclusion, discussion, proposed for the pharmaceutical industry counterparts in clinical safe, effective medication for reference. Keywords: Chuanhuning Injection respiratory tract infection, adverse reactions Chuanhuning injection, English name: Potassium Dehydroandrogrpholide Succinate Injection. Pinyin: Chuanhuning Zhusheye. Chuanhuning main components. Chemical Name: 14 - decarboxylase 11,12 - 2 dehydrogenation of andrographolide -3,19 - two single potassium succinate half-ester. Is mainly used for viral pneumonia, viral upper respiratory tract infection, a common drug for the treatment of respiratory diseases. In clinical treatment, nearly three years, 67 cases were observed Chuanhuning Injection drug adverse events. Clinical manifestations are as follows: allergic reaction (symptoms of facial flushing, dizziness, skin itching, and allergic shock reaction to the performance of) 18 cases (composition ratio of 26.87 percent, according to 67 cases 100% of the calculation, the following similar), fever in 7 patients (10.45%) , thrombocytopenia in 2 cases (2.99%), urticaria in 2 cases (2.99